Insider purchase at Radius Health (RDUS) prolongs buy activity of Last 90 Days

Monday, February 12, 2018 10:15 PM ET

Insider purchase at Radius Health (RDUS) prolongs buy activity of Last 90 Days

An insider — Biotech Growth N V, 10% Owner — bought 75,000 shares of Radius Health having a market value of approximately $2,578,763 today, as revealed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 50,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 125,000 shares and have averaged 62,500 shares per transaction over this time period.

The number of insider buy/sell trades at Radius Health is higher than that of the 281 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 329 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by Radius Health insiders is lower than its peers. Within the peer group there were 27,009,167 shares purchased and 43,772,508 shares sold with company insiders having sold 50,952 shares on average over this time period.

Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data obtained in creating and writing this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.